Clover Health Investments (CLOV) Operating Leases (2020 - 2024)

Clover Health Investments has reported Operating Leases for 5 years, with the latest figure at $2.3 million in Q3 2024.

• For the quarter ending Q3 2024, Operating Leases fell 29.5% year-over-year to $2.3 million; the trailing twelve-month figure through Sep 2024 stood at $2.3 million (down 29.5% YoY), and the FY2023 full-year result was $3.0 million, down 25.66% from the prior year.
• Operating Leases for Q3 2024 stood at $2.3 million, down from $2.5 million in the prior quarter.
• The five-year high for Operating Leases was $9.3 million in Q2 2021, with the low at $2.3 million in Q3 2024.
• Historically, Operating Leases has averaged $4.3 million across 5 years, with a median of $4.0 million in 2022.
• The largest YoY upside for Operating Leases was 11.44% in 2022 against a maximum downside of 50.52% in 2022.
• Clover Health Investments' Operating Leases stood at $6.3 million in 2020, then decreased by 23.93% to $4.8 million in 2021, then slipped by 16.5% to $4.0 million in 2022, then retreated by 25.66% to $3.0 million in 2023, then dropped by 22.58% to $2.3 million in 2024.
• The last three Operating Leases figures came in at $2.3 million (Q3 2024), $2.5 million (Q2 2024), and $2.7 million (Q1 2024), per Business Quant data.